| Patient First Home Care | |
| 2660 Horizon Dr Se, Suite 130, Grand Rapids, Michigan 49546 | |
| (616) 608-6246 | |
| Name | Patient First Home Care |
|---|---|
| Location | 2660 Horizon Dr Se, Suite 130, Grand Rapids, Michigan |
| Certified By | Medicare |
| Services Offered | Nursing Care Physical Therapy Occupational Therapy Speech Pathology Medical Social Services Home Health Aide |
| Medicare ID | 237616 |
| Ownership Type | Proprietary |
| Service Area Zip Codes | 48808, 48815, 48837, 48840, 48842, 48846, 48854, 48858, 48875, 48881, 48917, 48933, 49002, 49007, 49008, 49022, 49031, 49037, 49043, 49047, 49058, 49064, 49073, 49079, 49080, 49112, 49201, 49345, 49404, 49418, 49423, 49424, 49437, 49440, 49442, 49456, 49461, 49501, 49503, 49504, 49505, 49506, 49507, 49508, 49509, 49525 |
| NPI Number | 1639223423 |
| Organization Name | PATIENT FIRST HOME CARE, INC. |
| Address | 2660 Horizon Dr Se, Suite 130, Grand Rapids, MI 49546 |
| Phone Number | 616-608-6246 |
News Archive
The program - funded by U.S. Department of Labor - aims to raise public awareness of HIV prevention, protect employment rights of people living with the disease, and reduce stigma and discrimination in the workplace (Xinhua/People's Daily, 1/26).
Abbot and AstraZeneca have announced that they have entered into an agreement for AstraZeneca to co-promote Abbott's Trilipix (fenofibric acid), a medication for use alone or in combination with a statin to treat certain lipid disorders. Under the terms of the agreement, AstraZeneca will obtain the non-exclusive right to co-promote Trilipix alongside Abbott in the United States, excluding Puerto Rico. Specific financial terms were not disclosed.
Two draft guidance documents that address the use of nanotechnology by the food and cosmetics industries were issued today by the U.S. Food and Drug Administration.
Politico reports that the administration "is taking health insurers to task again, this time for choosing to no longer sell plans intended to cover sick children." Insurers "have said in recent weeks that they would stop selling 'child only' insurance plans because the overhaul requires them to accept all applicants, even if they apply for coverage at the last minute before treatment." In a letter to industry groups, Health and Human Services Secretary Kathleen Sebelius highlighted the "plight of millions of parents who desperately want to provide health coverage and critical treatments" in the face of insurer decisions.
Soon scientists may have a test to diagnose autism spectrum disorders using magnetic resonance imaging (MRI) scans. As of now this dreaded developmental disorder is typically diagnosed through observations, along with educational and psychological testing.
› Verified 9 days ago
| Quality Rating: |
News Archive
The program - funded by U.S. Department of Labor - aims to raise public awareness of HIV prevention, protect employment rights of people living with the disease, and reduce stigma and discrimination in the workplace (Xinhua/People's Daily, 1/26).
Abbot and AstraZeneca have announced that they have entered into an agreement for AstraZeneca to co-promote Abbott's Trilipix (fenofibric acid), a medication for use alone or in combination with a statin to treat certain lipid disorders. Under the terms of the agreement, AstraZeneca will obtain the non-exclusive right to co-promote Trilipix alongside Abbott in the United States, excluding Puerto Rico. Specific financial terms were not disclosed.
Two draft guidance documents that address the use of nanotechnology by the food and cosmetics industries were issued today by the U.S. Food and Drug Administration.
Politico reports that the administration "is taking health insurers to task again, this time for choosing to no longer sell plans intended to cover sick children." Insurers "have said in recent weeks that they would stop selling 'child only' insurance plans because the overhaul requires them to accept all applicants, even if they apply for coverage at the last minute before treatment." In a letter to industry groups, Health and Human Services Secretary Kathleen Sebelius highlighted the "plight of millions of parents who desperately want to provide health coverage and critical treatments" in the face of insurer decisions.
Soon scientists may have a test to diagnose autism spectrum disorders using magnetic resonance imaging (MRI) scans. As of now this dreaded developmental disorder is typically diagnosed through observations, along with educational and psychological testing.
› Verified 9 days ago
| Quality Measure | Provider | National Avg. |
|---|---|---|
| How often the home health team began their patients’ care in a timely manner | 98.2 | 95.7 |
| How often the home health team taught patients (or their family caregivers) about their drugs | 100 | 98.6 |
| How often the home health team checked patients’ risk of falling | 100 | 99.6 |
| How often the home health team checked patients for depression | 99.1 | 97.4 |
| How often the home health team made sure that their patients have received a flu shot for the current flu season. | 82.4 | 78.7 |
| How often the home health team made sure that their patients have received a pneumococcal vaccine (pneumonia shot). | 75.2 | 82.2 |
| With diabetes, how often the home health team got doctor’s orders, gave foot care, and taught patients about foot care | 100 | 96.4 |
News Archive
The program - funded by U.S. Department of Labor - aims to raise public awareness of HIV prevention, protect employment rights of people living with the disease, and reduce stigma and discrimination in the workplace (Xinhua/People's Daily, 1/26).
Abbot and AstraZeneca have announced that they have entered into an agreement for AstraZeneca to co-promote Abbott's Trilipix (fenofibric acid), a medication for use alone or in combination with a statin to treat certain lipid disorders. Under the terms of the agreement, AstraZeneca will obtain the non-exclusive right to co-promote Trilipix alongside Abbott in the United States, excluding Puerto Rico. Specific financial terms were not disclosed.
Two draft guidance documents that address the use of nanotechnology by the food and cosmetics industries were issued today by the U.S. Food and Drug Administration.
Politico reports that the administration "is taking health insurers to task again, this time for choosing to no longer sell plans intended to cover sick children." Insurers "have said in recent weeks that they would stop selling 'child only' insurance plans because the overhaul requires them to accept all applicants, even if they apply for coverage at the last minute before treatment." In a letter to industry groups, Health and Human Services Secretary Kathleen Sebelius highlighted the "plight of millions of parents who desperately want to provide health coverage and critical treatments" in the face of insurer decisions.
Soon scientists may have a test to diagnose autism spectrum disorders using magnetic resonance imaging (MRI) scans. As of now this dreaded developmental disorder is typically diagnosed through observations, along with educational and psychological testing.
› Verified 9 days ago
| Quality Measure | Provider | National Avg. |
|---|---|---|
| How often patients got better at walking or moving around | 72.4 | 79.6 |
| How often patients got better at getting in and out of bed | 89.2 | 81.1 |
| How often patients got better at bathing | 80.8 | 82.3 |
| How often patients’ breathing improved | 76.6 | 82.8 |
| How often patients’ wounds improved or healed after an operation | - | 92.3 |
| How often patients got better at taking their drugs correctly by mouth | 54.6 | 75 |
| How often home health patients had to be admitted to the hospital | 13.9 | 15.4 |
| How often patients receiving home health care needed urgent, unplanned care in the ER without being admitted | 8.4 | 13 |
| How often physician-recommended actions to address medication issues were completely timely | 95.5 | 94 |
News Archive
The program - funded by U.S. Department of Labor - aims to raise public awareness of HIV prevention, protect employment rights of people living with the disease, and reduce stigma and discrimination in the workplace (Xinhua/People's Daily, 1/26).
Abbot and AstraZeneca have announced that they have entered into an agreement for AstraZeneca to co-promote Abbott's Trilipix (fenofibric acid), a medication for use alone or in combination with a statin to treat certain lipid disorders. Under the terms of the agreement, AstraZeneca will obtain the non-exclusive right to co-promote Trilipix alongside Abbott in the United States, excluding Puerto Rico. Specific financial terms were not disclosed.
Two draft guidance documents that address the use of nanotechnology by the food and cosmetics industries were issued today by the U.S. Food and Drug Administration.
Politico reports that the administration "is taking health insurers to task again, this time for choosing to no longer sell plans intended to cover sick children." Insurers "have said in recent weeks that they would stop selling 'child only' insurance plans because the overhaul requires them to accept all applicants, even if they apply for coverage at the last minute before treatment." In a letter to industry groups, Health and Human Services Secretary Kathleen Sebelius highlighted the "plight of millions of parents who desperately want to provide health coverage and critical treatments" in the face of insurer decisions.
Soon scientists may have a test to diagnose autism spectrum disorders using magnetic resonance imaging (MRI) scans. As of now this dreaded developmental disorder is typically diagnosed through observations, along with educational and psychological testing.
› Verified 9 days ago
| Question Type: | Rating by Patients |
|---|---|
| Health team gave care in a professional way | Not Available |
| Health team communicated well with them | Not Available |
| Health team discussed medicines, pain, and home safety | Not Available |
| How patients rated overall care from agency | Not Available |
News Archive
The program - funded by U.S. Department of Labor - aims to raise public awareness of HIV prevention, protect employment rights of people living with the disease, and reduce stigma and discrimination in the workplace (Xinhua/People's Daily, 1/26).
Abbot and AstraZeneca have announced that they have entered into an agreement for AstraZeneca to co-promote Abbott's Trilipix (fenofibric acid), a medication for use alone or in combination with a statin to treat certain lipid disorders. Under the terms of the agreement, AstraZeneca will obtain the non-exclusive right to co-promote Trilipix alongside Abbott in the United States, excluding Puerto Rico. Specific financial terms were not disclosed.
Two draft guidance documents that address the use of nanotechnology by the food and cosmetics industries were issued today by the U.S. Food and Drug Administration.
Politico reports that the administration "is taking health insurers to task again, this time for choosing to no longer sell plans intended to cover sick children." Insurers "have said in recent weeks that they would stop selling 'child only' insurance plans because the overhaul requires them to accept all applicants, even if they apply for coverage at the last minute before treatment." In a letter to industry groups, Health and Human Services Secretary Kathleen Sebelius highlighted the "plight of millions of parents who desperately want to provide health coverage and critical treatments" in the face of insurer decisions.
Soon scientists may have a test to diagnose autism spectrum disorders using magnetic resonance imaging (MRI) scans. As of now this dreaded developmental disorder is typically diagnosed through observations, along with educational and psychological testing.
› Verified 9 days ago
The patient survey data of Patient First Home Care is compared against the national average with the color code indicators: Better than National Average Worse than National Average| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percent of patients who reported that their home health team gave care in a professional way | 77 | 88 |
| Percent of patients who reported that their home health team communicated well with them | 77 | 85 |
| Percent of patients who reported that their home health team discussed medicines, pain, and home safety with them | 74 | 83 |
| Percent of patients who gave their home health agency a rating of 9 or 10 on a scale from 0 (lowest) to 10 (highest) | 73 | 84 |
| Percent of patients who reported YES, they would definitely recommend the home health agency to friends and family | 62 | 78 |
News Archive
The program - funded by U.S. Department of Labor - aims to raise public awareness of HIV prevention, protect employment rights of people living with the disease, and reduce stigma and discrimination in the workplace (Xinhua/People's Daily, 1/26).
Abbot and AstraZeneca have announced that they have entered into an agreement for AstraZeneca to co-promote Abbott's Trilipix (fenofibric acid), a medication for use alone or in combination with a statin to treat certain lipid disorders. Under the terms of the agreement, AstraZeneca will obtain the non-exclusive right to co-promote Trilipix alongside Abbott in the United States, excluding Puerto Rico. Specific financial terms were not disclosed.
Two draft guidance documents that address the use of nanotechnology by the food and cosmetics industries were issued today by the U.S. Food and Drug Administration.
Politico reports that the administration "is taking health insurers to task again, this time for choosing to no longer sell plans intended to cover sick children." Insurers "have said in recent weeks that they would stop selling 'child only' insurance plans because the overhaul requires them to accept all applicants, even if they apply for coverage at the last minute before treatment." In a letter to industry groups, Health and Human Services Secretary Kathleen Sebelius highlighted the "plight of millions of parents who desperately want to provide health coverage and critical treatments" in the face of insurer decisions.
Soon scientists may have a test to diagnose autism spectrum disorders using magnetic resonance imaging (MRI) scans. As of now this dreaded developmental disorder is typically diagnosed through observations, along with educational and psychological testing.
› Verified 9 days ago
Visiting Nurse Services Of Western Michigan Location: 1401 Cedar Ne, Grand Rapids, Michigan 49503 Ratings: Phone: (616) 486-3900 | |
Mary Free Bed At Home Location: 4280 Cascade Rd, Grand Rapids, Michigan 49546 Ratings: Phone: (616) 942-5570 | |
Atrio Home Health Location: 2100 Raybrook Se, Grand Rapids, Michigan 49546 Ratings: Phone: (616) 235-4663 | |
Mercy Health Home Care, Grand Rapids Location: 1430 Monroe Nw, Suite 120, Grand Rapids, Michigan 49505 Ratings: Phone: (616) 685-8800 | |
Kindred At Home Location: 625 Kenmoor Se Ave, Ste 306, Grand Rapids, Michigan 49546 Ratings: Phone: (616) 942-5744 | |
Porter Hills Home Health Care Location: 4450 Cascade Rd Se, Grand Rapids, Michigan 49546 Ratings: Phone: (616) 949-5140 |